688658 悅康藥業
按盤價 
19.080 +1.860 (+10.801%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.387 | 3.453 | 4.878 | 8.472 | 14.533 |
| 總資產報酬率 ROA (%) | -0.868 | 2.124 | 3.101 | 5.712 | 9.752 |
| 投入資產回報率 ROIC (%) | -1.088 | 2.801 | 4.152 | 7.546 | 13.012 | 邊際利潤分析 |
| 銷售毛利率 (%) | 44.781 | 57.801 | 62.671 | 64.645 | 69.242 |
| 營業利潤率 (%) | -10.124 | 4.207 | 5.523 | 7.881 | 12.824 |
| 息稅前利潤/營業總收入 (%) | -9.598 | 4.161 | 5.076 | 6.976 | 12.006 |
| 淨利潤/營業總收入 (%) | -8.573 | 3.207 | 4.468 | 7.462 | 10.950 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 87.878 | 142.742 | 105.690 | 99.087 | 103.019 |
| 價值變動淨收益/利潤總額(%) | -1.005 | 1.829 | -0.451 | 1.138 | 0.641 |
| 營業外收支淨額/利潤總額(%) | 0.978 | -4.401 | -3.800 | -2.407 | -1.200 | 償債能力分析 |
| 流動比率 (X) | 2.167 | 2.098 | 1.603 | 2.054 | 2.417 |
| 速動比率 (X) | 1.707 | 1.595 | 1.262 | 1.665 | 2.041 |
| 資產負債率 (%) | 36.994 | 37.524 | 39.139 | 33.474 | 31.426 |
| 帶息債務/全部投入資本 (%) | 18.843 | 18.286 | 13.630 | 10.935 | 5.554 |
| 股東權益/帶息債務 (%) | 414.719 | 431.127 | 612.764 | 792.225 | 1,651.120 |
| 股東權益/負債合計 (%) | 169.970 | 166.158 | 155.074 | 198.333 | 218.025 |
| 利息保障倍數 (X) | -15.332 | 31.635 | -20.734 | -9.695 | -18.029 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 92.511 | 71.672 | 91.007 | 81.032 | 50.078 |
| 存貨周轉天數 (天) | 197.995 | 167.538 | 168.463 | 153.642 | 148.364 |
| 備註： | 即時報價更新時間為 16/06/2025 12:33 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
